Govt Job: For the post of Director Vigilance in CDSCO

The Central Drugs Standard Control Organisation (CDSCO) under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, is the National Regulatory Authority (NRA) of India.

Its headquarter is located at FDA Bhawan, Kotla Road, New Delhi 110002, and also has six zonal offices, four sub-zonal offices, thirteen Port offices, and seven laboratories spread across the country.

Post: Director (Vigilance)

Applications are invited from eligible candidates for appointment on deputation (including short-term contract) basis to the post of Director (Vigilance), Group ‘A’, Level 13 (Rs. 1,23,100–2,15,900) (revised) in the Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare, New Delhi.

Pay : Level 13 (Rs. 1,23,100-2,15,900)

Method of recruitment Eligibility Criteria : Deputation (including short-term contract) Officers of the Central Government or the State Governments or Union territories or Universities or recognized Research Institutions or Public Sector Undertakings or semi-Government or Statutory or Autonomous Organisations who have completed fourteen years of Group ‘A’ service and have been granted non- functional Selection Grade (NFSG) in their respective cadre.

Note 1: Selection and appointment for the post of Director (Vigilance) are to be made in accordance with the guidelines circulated by the DOP&T vide their O.M. No. 372/8/99-AVD.

II dated 18.01.2001 on the subject “Procedure for selection and appointment of Chief Vigilance Officers in the various Central Public Sector Undertakings: and as amended from time to time

Note 2: Period of deputation (including Short Term Contract) including the period of deputation (including Short Term Contract) in another ex-cadre post held immediately preceding this appointment in the same or some other organization or department of the Central Government shall not exceed five years.

Note 3: The maximum age limit for appointment by deputation shall not be exceeding 56 years as of the closing date of receipt of applications.

To exercise check and supervision on vigilance and anti-corruption work in the Central Drugs Standard Control Organization as per rules laid down in the Vigilance Manual and instructions of the Central Vigilance Commission.

The list of enclosures to be sent with the application

1. Application in prescribed format – Annexure-II duly filled, signed by the candidate and countersigned with seal by the Cadre/Appointing authority.

2. Attested copies of APARs/ACRs for the last 5 (five) years duly attested on each page with seal by an officer, not below the rank of Under Secretary to the Government of India

3. Integrity Certificate

4. Vigilance Clearance Certificate

5. Statement of major or minor penalties, if any, imposed on the officer during the last 10 years of service.

6. A certificate to the effect that the particulars furnished by the candidate have been verified and found correct as per service records.

7. Cadre Clearance Certificate

Note: Incomplete applications or applications not accompanied by the above documents will be summarily rejected.

The Cadre authorities/Head of Departments are requested to forward applications of eligible and willing candidates whose services can be spared on a deputation (including short-term contract) basis so as to reach the undersigned within 60 days from the date of publication of this advertisement in the Employment News.

The Application Form/Curriculum Vitae proforma is in Annexure II.

Directorate General of Health Services
Central Drugs Standard Control Organization (HQ),
FDA Bhawan, Kotla Road, New Delhi

Related Posts

AbbVie loses patent plea for Hep C drug

New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…

GSK’s Calpol a well-known trademark: High Court

New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer